Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome

American Journal of Transplantation

Volumn 9, Issue 8, 2009, Pages 1903-1911

  Weigt, S S ^a   Elashoff, R M ^b   Huang, C ^a   Ardehali, A ^a   Gregson, A L ^a   Kubak, B ^a   Fishbein, M C ^a   Saggar, R ^a   Keane, M P ^c   Lynch Iii, J P ^a   Zisman, D A ^a   Ross, D J ^a   Belperio, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Aspergillus; Bronchiolitis obliterans syndrome; Chronic rejection; Fungal infection; Lung transplantation; Rejection

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; BASILIXIMAB; CASPOFUNGIN; COTRIMOXAZOLE; GANCICLOVIR; IMMUNOGLOBULIN; ITRACONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VORICONAZOLE;

ADULT; AGED; ALLOGRAFT; ARTICLE; ASPERGILLUS; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FUNGAL COLONIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LUNG ASPERGILLOSIS; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SPUTUM CULTURE;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; BRONCHIOLITIS OBLITERANS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 67650954171     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02635.x     Document Type: Article

References (41)

1. Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007 26 : 681 686.
2. Trulock EP, Christie JD, Edwards LB et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007 26 : 782 795.
3. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998 17 : 1255 1263.
4. Keenan RJ, Lega ME, Dummer JS et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991 51 : 433 438.
5. Keller CA, Cagle PT, Brown RW, Noon G, Frost AE. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 1995 107 : 973 980.
6. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM, III. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997 114 : 195 202.
7. Reichenspurner H, Girgis RE, Robbins RC et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996 62 : 1467 1472 discussion 1472-1463.
8. Smith MA, Sundaresan S, Mohanakumar T et al. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 1998 116 : 812 820. (Pubitemid 28499176)
9. Weigt SS, Elashoff RM, Keane MP et al. Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation. Am J Transplant 2008.
10. Neurohr C, Huppmann P, Leuchte H et al. Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: A risk factor for bronchiolitis obliterans syndrome? Am J Transplant 2005 5 : 2982 2991.
11. Kotsimbos TC, Snell GI, Levvey B et al. Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2005 79 : 269 275.
12. Glanville AR, Gencay M, Tamm M et al. Chlamydia pneumoniae infection after lung transplantation. J Heart Lung Transplant 2005 24 : 131 136.
13. Khalifah AP, Hachem RR, Chakinala MM et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004 170 : 181 187.
14. Kumar D, Erdman D, Keshavjee S et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005 5 : 2031 2036.
15. Botha P, Archer L, Anderson RL et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008 85 : 771 774.
16. Vos R, Vanaudenaerde BM, Geudens N, Dupont LJ, Van Raemdonck DE, Verleden GM. Pseudomonal airway colonization: A risk factor for BOS after lung transplantation? Eur Respir J 2008.
17. Cahill BC, Hibbs JR, Savik K et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997 112 : 1160 1164.
18. Iversen M, Burton CM, Vand S et al. Aspergillus infection in lung transplant patients: Incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007.
19. Mehrad B, Paciocco G, Martinez FJ, Ojo TC, Iannettoni MD, Lynch JP, 3rd. Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature. Chest 2001 119 : 169 175.
20. Patterson JE, Peters J, Calhoon JH et al. Investigation and control of Aspergillosis and other filamentous fungal infections in solid organ transplant recipients. Transpl Infect Dis 2000 2 : 22 28.
21. Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection : Lung Rejection Study Group. J Heart Lung Transplant 1996 15 (1 Pt 1 1 15.
22. Husain AN, Siddiqui MT, Holmes EW et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999 159 : 829 833.
23. Cooper JD, Billingham M, Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993 12 : 713 716.
24. Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297 310.
25. George MJ, Snydman DR, Werner BG et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 1997 103 : 106 113.
26. Mattner F, Chaberny IF, Weissbrodt H et al. [Surveillance of invasive mold infections in lung transplant recipients: Effect of antimycotic prophylaxis with itraconazole and voriconazole]. Mycoses 2005 48 (Suppl 1 51 55.
27. Monforte V, Roman A, Gavalda J et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: Study of risk factors. J Heart Lung Transplant 2001 20 : 1274 1281.
28. Singh N, Husain S. Aspergillus infections after lung transplantation: Clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003 22 : 258 266.
29. Westney GE, Kesten S, De Hoyos A, Chapparro C, Winton T, Maurer JR. Aspergillus infection in single and double lung transplant recipients. Transplantation 1996 61 : 915 919.
30. Martins PN, Pratschke J, Pascher A et al. Age and immune response in organ transplantation. Transplantation 2005 79 : 127 132.
31. Hadjiliadis D, Sporn TA, Perfect JR, Tapson VF, Davis RD, Palmer SM. Outcome of lung transplantation in patients with mycetomas. Chest 2002 121 : 128 134.
32. Helmi M, Love RB, Welter D, Cornwell RD, Meyer KC. Aspergillus infection in lung transplant recipients with cystic fibrosis: Risk factors and outcomes comparison to other types of transplant recipients. Chest 2003 123 : 800 808.
33. Husni RN, Gordon SM, Longworth DL et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998 26 : 753 755.
34. Girgis RE, Tu I, Berry GJ et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 1996 15 : 1200 1208.
35. Sole A, Morant P, Salavert M, Peman J, Morales P. Aspergillus infections in lung transplant recipients: Risk factors and outcome. Clin Microbiol Infect 2005 11 : 359 365.
36. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008 46 : 1813 1821.
37. Hummel M, Schuler S, Hempel S, Rees W, Hetzer R. Obstructive bronchial aspergillosis after heart transplantation. Mycoses 1993 36 : 425 428.
38. Borger P, Koeter GH, Timmerman JA, Vellenga E, Tomee JF, Kauffman HF. Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis 1999 180 : 1267 1274.
39. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000 105 (6 Pt 1 1185 1193.
40. Tomee JF, Kauffman HF. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000 30 : 476 484.
41. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997 176 : 300 303.